Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$9,072,601
-$2,271,977 QoQ
Shares Held
71,811
-11.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#447
of 2,266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Channing Capital Management, LLC holds $25,323,008 across 2 Drug Manufacturers - General names. GILD ranks #2 (35.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
64,578 | $16,250,407 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
71,811 | $9,072,601 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,072,601 | 71,811 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $11,344,578 | 81,399 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,499,387 | 93,689 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,272,716 | 101,556 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,295,879 | 101,884 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,499,908 | 58,009 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,113,039 | 98,658 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $8,803,619 | 105,005 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||